Currently out of the existing stock ratings of Eric Le Berrigaud, 2 are a HOLD (28.57%), 5 are a BUY (71.43%).

Eric Le Berrigaud

Work Performance Price Targets & Ratings Chart

Analyst Eric Le Berrigaud works at STIFEL with a stock forecast success ratio of 13.33% fulfilled within 52.2 days on average.

Eric Le Berrigaud’s has documented 23 price targets and ratings displayed on 6 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on SNY, Sanofi ADR at 30-Oct-2023.

Wall Street Analyst Eric Le Berrigaud

Analyst best performing recommendations are on NVS (NOVARTIS AG ADR).
The best stock recommendation documented was for NVS (NOVARTIS AG ADR) at 12/5/2022. The price target of $95 was fulfilled within 121 days with a profit of $7.83 (8.98%) receiving and performance score of 0.74.

Average potential price target upside

SNY Sanofi ADR NVS Novartis AG ADR AZN AstraZeneca PLC ADR GSK GlaxoSmithKline PLC ADR NVO Novo Nordisk A/S RHHBY Roche Holding Ltd ADR

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

55

$7.85 (16.65%)

121.04

3 months ago

0/10 (0%)

$5.11 (10.24%)

Buy

115.07

$67.92 (144.05%)

101.24

3 months 15 days ago

0/3 (0%)

$63.08 (121.33%)

Buy

64

$16.85 (35.74%)

3 months 20 days ago

0/3 (0%)

$13.39 (26.46%)

Buy

56

$8.85 (18.77%)

55

5 months 8 days ago

0/8 (0%)

$10.58 (23.29%)

Buy

98.04

$50.89 (107.93%)

117.53

5 months 20 days ago

0/7 (0%)

$52.24 (114.06%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Eric Le Berrigaud is most bullish on?

Potential upside of $54.09 has been obtained for SNY (SANOFI ADR)

What Year was the first public recommendation made by Eric Le Berrigaud?

On 2022

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?